MDxHealth SA (MDXH) Common Equity (2020 - 2024)

MDxHealth's Common Equity history spans 5 years, with the latest figure at $14.8 million for Q4 2024.

  • For Q4 2024, Common Equity rose 105.9% year-over-year to $14.8 million; the TTM value through Dec 2024 reached $14.8 million, up 105.9%, while the annual FY2024 figure was $14.8 million, 105.9% up from the prior year.
  • Common Equity for Q4 2024 was $14.8 million at MDxHealth, up from $7.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $46.9 million in Q4 2021 and bottomed at $5.8 million in Q4 2020.
  • The 5-year median for Common Equity is $9.3 million (2022), against an average of $16.8 million.
  • The largest annual shift saw Common Equity surged 701.83% in 2021 before it crashed 80.14% in 2022.
  • A 5-year view of Common Equity shows it stood at $5.8 million in 2020, then soared by 701.83% to $46.9 million in 2021, then plummeted by 80.14% to $9.3 million in 2022, then fell by 22.62% to $7.2 million in 2023, then surged by 105.9% to $14.8 million in 2024.
  • Per Business Quant, the three most recent readings for MDXH's Common Equity are $14.8 million (Q4 2024), $7.2 million (Q4 2023), and $9.3 million (Q4 2022).